LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individu…
Author: Business Wire
National Vision Holdings, Inc. Reports First Quarter 2021 Financial Results; Raises Fiscal 2021 Outlook
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the first quarter ended April 3, 2021. Reade Fahs, chief executive officer, stated,“It was a truly …
Oxford Finance Provides $125 Million Credit Facility to Kala Pharmaceuticals
ALEXANDRIA, Va.–(BUSINESS WIRE)–Oxford Finance Provides $125 Million Credit Facility to Kala Pharmaceuticals
Modernizing Medicine® Releases Enhanced Ophthalmic Image Management to Improve Clinical Workflow Automation and Efficiency
BOCA RATON, Fla.–(BUSINESS WIRE)–Specialty-specific healthcare information technology leader Modernizing Medicine® today announced it has released the latest version of ophthalmic Image Management to help ophthalmologists save time and deliver effici…
National Vision Collaborates with Americares and RestoringVision to Bring Sight to Half a Million People Living in Poverty in the U.S.
DULUTH, Ga.–(BUSINESS WIRE)—- $EYE #diversity–National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, announced today a new philanthropic collaboration with Ame…
Tilak Healthcare Launches US Pilot for OdySight Medical Vision Monitoring App
PARIS–(BUSINESS WIRE)–Tilak Healthcare, a digital therapeutics pioneer specializing in the development of mobile medical application games used as monitoring and rehabilitation tools for chronic diseases, is launching a pilot program in the US with N…
ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions
MARIETTA, Ohio–(BUSINESS WIRE)—- $PKTX #AMD–ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions
Global Optical Microscopes Market (2021 to 2025) – Featuring Bruker, Carl Zeiss and Danaher Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Optical Microscopes Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. The publisher has been monitoring the optical microscopes market and it is poised to grow by $603.53 million during 2…
Second Sight Medical Products Announces Two-Year Results of its Orion Study
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for b…
2020 On-site Closes Final Tranche of $8MM Growth Financing
BOSTON–(BUSINESS WIRE)–2020 On-site, a Boston-based mobile optometry company whose mission is to expand access to high-quality vision care including clinical research, has raised an additional $3.5 million in growth capital to complete an $8M investm…
Worldwide Tonometers Industry to 2025 – Key Drivers, Challenges and Trends – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Tonometers Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. The publisher has been monitoring the tonometers market and it is poised to grow by $47.61 million during 2021-2025, progressi…
Case Study Series Published in Journal of Neuroscience Nursing Demonstrates NeurOptics’ Pupillometry is Key Tool for Neurological Assessment
IRVINE, Calif.–(BUSINESS WIRE)– #brain–New case study shows NeurOptics’ pupillometry provides reliable pupil reactivity measurements that may impact treatment decisions for stroke patients.
Omeros Corporation Reports First Quarter 2021 Financial Results
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications ta…
Eye Health America’s Growth Continues with the Onboarding of a Leading Retina Specialist in Upstate South Carolina
GREENVILLE, S.C.–(BUSINESS WIRE)–Piedmont Retina Associates, led by Dr. Nick McLane, MD officially joined the Eye Health America (EHA)/Clemson Eye family on April 30th. Dr. McLane has been a leader in vitreoretinal eyecare in the Upstate for over 35 …
EyeSouth Partners Expands Presence in North Georgia with Georgia Eye Physicians and Surgeons Affiliation
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Georgia Eye Physicians and Surgeons (“GEPS”). The affiliation represents EyeSouth’s tenth in the state of Georgia…
National Vision’s Reade Fahs Signs CEO Action for Diversity and Inclusion™ Pledge
DULUTH, Ga.–(BUSINESS WIRE)—- $EYE #CEO–National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, announced today that Chief Executive Officer, Reade Fahs, has be…
Gyroscope Therapeutics Postpones Initial Public Offering
LONDON–(BUSINESS WIRE)–Gyroscope Therapeutics postpones initial public offering.
NovaBay Pharmaceuticals Reports First Quarter 2021 Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three months ended March 31, 2021 and provides a business update. “Our focus on the OTC channel is paying off as Avenova direct-t…
Global Veterinary Eye Care Market (2021 to 2026) – Growth, Trends, and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Veterinary Eye Care Market – Growth, Trends, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering. Veterinary Eye Care Market is expected to envision a CAGR of 3% during the forecast peri…
Kala Pharmaceuticals to Present at BofA Securities 2021 Healthcare Conference
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present a…